Skip to main content
GutCited

Fructooligosaccharides (FOS) per Chronic Constipation

C

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

In sintesi

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None vs: None Outcome: gut health outcomes including microbiota modulation and SCFA … Effetto: None None

Popolazione: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None vs: Placebo Outcome: Weekly spontaneous bowel movements Effetto: 4.94 vs 3.00 (P<0.001) P<0.001

Popolazione: Older adults >=60 with functional constipation (Rome IV)

Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g vs: None Outcome: Constipation symptoms Effetto: None P < 0.05

Popolazione: Constipation patients

Randomized Controlled Trial Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g vs: Placebo Outcome: Constipation symptoms Effetto: None None

Popolazione: Constipation patients

Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None vs: None Outcome: Constipation symptoms Effetto: OR: 10.36 p < 0.00001

Popolazione: Constipation patients

Randomized Controlled Trial Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None vs: Placebo Outcome: Constipation symptoms Effetto: None None

Popolazione: Constipation patients

Key Statistics

4

Studi

350

Partecipanti

Positive

C

Grado

Referenced Papers

Journal of Parkinson's … 2024 4 citazioni
Journal of physiology … 2009 312 citazioni
Journal of the … 2007 84 citazioni
BioFactors (Oxford, England) 2004 48 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

Limite massimo: Well-tolerated up to 20 g/day; start low to avoid excess gas

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None 4 weeks Positive 67
2 g -- Neutral --
6 g -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Momento migliore per l'assunzione: With meals; divide doses throughout the day

Safety & Side Effects

Effetti collaterali segnalati

  • Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • Abdominal cramping at higher doses
  • May worsen IBS symptoms in FODMAP-sensitive individuals
  • Loose stools at excessive doses

Interazioni note

  • Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • Calcium supplements (FOS may enhance calcium absorption)

Livello di assunzione massimo tollerabile: Well-tolerated up to 20 g/day; start low to avoid excess gas

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Chronic Constipation

Fructooligosaccharides (FOS) per altre condizioni

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.